COVID-19 in subjects at risk participating in clinical trials during the pandemic in Argentina
Description
CONCLUSION: The rate of COVID-19 in adult subjects participating in clinical trials was below the figures for the Argentine population of similar age. The fatality rate was above the population figures, and it is explained by the high risk of the
